Cary Street Partners Financial LLC Gilead Sciences, Inc. Transaction History
Cary Street Partners Financial LLC
- $3.16 Trillion
- Q1 2025
A detailed history of Cary Street Partners Financial LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Cary Street Partners Financial LLC holds 6,194 shares of GILD stock, worth $667,217. This represents 0.02% of its overall portfolio holdings.
Number of Shares
6,194
Previous 6,347
2.41%
Holding current value
$667,217
Previous $586 Million
18.38%
% of portfolio
0.02%
Previous 0.02%
Shares
2 transactions
Others Institutions Holding GILD
# of Institutions
2,286Shares Held
997MCall Options Held
9.62MPut Options Held
10M-
Black Rock Inc. New York, NY121MShares$13 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA117MShares$12.7 Billion0.25% of portfolio
-
State Street Corp Boston, MA59.5MShares$6.41 Billion0.28% of portfolio
-
Capital Research Global Investors Los Angeles, CA54.6MShares$5.88 Billion1.39% of portfolio
-
Capital World Investors Los Angeles, CA53.5MShares$5.77 Billion1.01% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $135B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...